Cargando…
A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers
Some experimental and clinical studies have been conducted for the usage of chemotherapeutic drugs encapsulated into nanoparticles (NPs). However, no study has been conducted so far on the co-encapsulation of doxorubicin (Dox) and epoxomicin (Epo) into NPs as biocompatible drug delivery carriers. Th...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219778/ https://www.ncbi.nlm.nih.gov/pubmed/34158544 http://dx.doi.org/10.1038/s41598-021-92447-x |